 |
|
Liver Histiocytes in Rejection of Tumor CellsPreliminary Studies With the Isolated, Perfused Rodent Liver
Said Draz, MD, FRCS;
John E. Byfield, MD;
Patricia Byfield, PhD;
Eric W. Fonkalsrud, MD
AMA Arch Surg. 1971;102(6):574-577.
Abstract
The role of hepatic histiocytes in the immune rejection of tumor cells has been evaluated in the isolated perfused rodent liver. The active phagocytosis of technitium sulfide Tc 99m in vitro by the liver reticuloendothelial system demonstrated the effectiveness of this preparation. Immunization enhanced the cytotoxicity of the isolated peritoneal macrophage to xenogeneic cells. The addition of immunized serum caused a pronounced increase in this phenomenon. Progressive removal of histoincompatible cells from the perfusate was detected in both immunized and nonimmunized isolated liver preparations. No significant differences were observed between the systems, although serum was lacking, and cell-fixed antibodies or complement may be required for Kupffer's cell cytotoxicity. The isolated, perfused rodent liver appears to be useful for studying the initial phases of tumor antigen processing in an organ which maintains its structural integrity.
Author Affiliations
Los Angeles
From the departments of surgery (Drs. Draz, P.E. Byfield, and Fonkalsrud) and radiology (Dr. J.E. Byfield), University of California School of Medicine, Los Angeles.
Footnotes
Accepted for publication Feb 5, 1971.
Read before the annual meeting of the Southern California Chapter of the American College of Surgeons, Palm Springs, Calif, Jan 15, 1971.
Reprint requests to Department of Surgery, University of California School of Medicine, Los Angeles 90024 (Dr. Fonkalsrud).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
